{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:36:57Z","timestamp":1792417017724,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01440-5","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:24:04Z","timestamp":1771550644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel polymorphism in the TERT gene is associated with lower survival in male patients with melanoma"],"prefix":"10.1186","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-9745","authenticated-orcid":false,"given":"Maria Santa","family":"Rocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-9210","authenticated-orcid":false,"given":"Andrea","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-8014","authenticated-orcid":false,"given":"Paolo","family":"Del Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-1122","authenticated-orcid":false,"given":"Fortunato","family":"Cassalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-2471","authenticated-orcid":false,"given":"Clara","family":"Benna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5998-8146","authenticated-orcid":false,"given":"Ilaria","family":"Cosci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8445","authenticated-orcid":false,"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-8141","authenticated-orcid":false,"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"1440_CR1","doi-asserted-by":"publisher","unstructured":"Akincilar SC, Unal B, Tergaonkar V. Reactivation of telomerase in cancer. Cell Mol Life Sci. 2016;73(8). https:\/\/doi.org\/10.1007\/s00018-016-2146-9.","DOI":"10.1007\/s00018-016-2146-9"},{"key":"1440_CR2","doi-asserted-by":"publisher","unstructured":"Alsurhi TN, Shalaby A, Al-Sinawi S, Mabruk M. Assessment of telomeres expression in melanoma and cutaneous squamous cell carcinoma: correlation with clinical parameters. Clin Transl Oncol. 2025;27(9):3763\u20139. https:\/\/doi.org\/10.1007\/s12094-025-03876-3.","DOI":"10.1007\/s12094-025-03876-3"},{"key":"1440_CR3","doi-asserted-by":"publisher","unstructured":"Andreikos DA, Spandidos DA. Telomere length and skin cancer risk: A systematic review and meta\u2011analysis of melanoma, basal cell carcinoma and squamous cell carcinoma. Oncol Lett. 2025;30(2). https:\/\/doi.org\/10.3892\/ol.2025.15141.","DOI":"10.3892\/ol.2025.15141"},{"key":"1440_CR4","doi-asserted-by":"publisher","unstructured":"Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, et al. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 2013;37(4). https:\/\/doi.org\/10.3892\/ol.2025.15141.","DOI":"10.3892\/ol.2025.15141"},{"key":"1440_CR5","doi-asserted-by":"publisher","unstructured":"Baird DM. Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med. 2010;12:e16. https:\/\/doi.org\/10.1017\/S146239941000147X.","DOI":"10.1017\/S146239941000147X"},{"key":"1440_CR6","doi-asserted-by":"publisher","unstructured":"Bell RJA, Rube HT, Xavier-Magalh\u00e3es A, Costa BM, Mancini A, Song JS, et al. Understanding TERT promoter mutations: a common path to immortality. Mol Cancer Res. 2016;14(4). https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0003.","DOI":"10.1158\/1541-7786.MCR-16-0003"},{"key":"1440_CR7","doi-asserted-by":"publisher","unstructured":"Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Car\u00e8 A, Mattia G. Sex and gender disparities in melanoma. Cancers. 2020;12(7). https:\/\/doi.org\/10.3390\/cancers12071819.","DOI":"10.3390\/cancers12071819"},{"key":"1440_CR8","doi-asserted-by":"publisher","unstructured":"Benna C, Rajendran S, Spiro G, Menin C, Dall\u2019Olmo L, Rossi CR, et al. Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility. J Transl Med. 2021;19(1). https:\/\/doi.org\/10.1186\/s12967-021-02725-5.","DOI":"10.1186\/s12967-021-02725-5"},{"key":"1440_CR9","doi-asserted-by":"publisher","unstructured":"Bernadotte A, Mikhelson VM, Spivak IM. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging Albany NY. 2016;8(1). https:\/\/doi.org\/10.1186\/s12967-021-02725-5.","DOI":"10.1186\/s12967-021-02725-5"},{"key":"1440_CR10","doi-asserted-by":"publisher","unstructured":"Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013;45(4). https:\/\/doi.org\/10.1038\/ng.2566.","DOI":"10.1038\/ng.2566"},{"key":"1440_CR11","doi-asserted-by":"publisher","unstructured":"Buja A, Rugge M, Cozzolino C, Dossi F, Zorzi M, Vecchiato A, et al. Could the mitotic count improve personalized prognosis in melanoma patients? PLoS One. 2024;19(4 April). https:\/\/doi.org\/10.1371\/journal.pone.0302309.","DOI":"10.1371\/journal.pone.0302309"},{"key":"1440_CR12","doi-asserted-by":"publisher","unstructured":"Campos C, Fragoso S, Lu\u00eds R, Pinto F, Brito C, Esteves S, et al. High-throughput sequencing identifies 3 novel susceptibility genes for hereditary melanoma. Genes (Basel). 2020;11(4). https:\/\/doi.org\/10.3390\/genes11040403.","DOI":"10.3390\/genes11040403"},{"key":"1440_CR13","doi-asserted-by":"publisher","unstructured":"Carvalho L, Lipay M, Belfort F, Santos I, Andrade J, Haddad A, et al. Telomerase activity in prognostic histopathologic features of melanoma. J Plast Reconstr Aesthet Surg. 2006;59(9). https:\/\/doi.org\/10.1016\/j.bjps.2006.01.022.","DOI":"10.1016\/j.bjps.2006.01.022"},{"key":"1440_CR14","doi-asserted-by":"publisher","unstructured":"Chrysanthou E, Sehovic E, Ostano P, Chiorino G. Comprehensive gene expression analysis to identify differences and similarities between sex-and stage-stratified melanoma samples. Cells. 2022;11(7). https:\/\/doi.org\/10.3390\/cells11071099.","DOI":"10.3390\/cells11071099"},{"key":"1440_CR15","doi-asserted-by":"publisher","unstructured":"Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S, et al. Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021;53(10). https:\/\/doi.org\/10.1038\/s41588-021-00944-6.","DOI":"10.1038\/s41588-021-00944-6"},{"key":"1440_CR16","doi-asserted-by":"publisher","unstructured":"Cosci I, Grande G, Di Nisio A, Rocca MS, Del Fiore P, Benna C, et al. Cutaneous melanoma and hormones: focus on sex differences and the testis. Intern J Mol Sci 2023;24(1). https:\/\/doi.org\/10.3390\/ijms24010599.","DOI":"10.3390\/ijms24010599"},{"key":"1440_CR17","doi-asserted-by":"crossref","unstructured":"Cosci I, Salizzato V, Del Fiore P, Pigozzo J, Guarneri V, Mocellin S, et al. Molecular basis of BRAF inhibitor resistance in melanoma: a systematic review. Pharmaceuticals. 2025;18(8):1235. Available from: https:\/\/www.mdpi.com\/1424-8247\/18\/8\/1235","DOI":"10.3390\/ph18081235"},{"key":"1440_CR18","doi-asserted-by":"publisher","unstructured":"Davis EJ, Johnson DB, Sosman JA, Chandra S. Melanoma: What do all the mutations mean? Cancer. 2018;124(17). https:\/\/doi.org\/10.1002\/cncr.31345.","DOI":"10.1002\/cncr.31345"},{"key":"1440_CR19","doi-asserted-by":"publisher","unstructured":"Di Donato M, Cristiani CM, Capone M, Garofalo C, Madonna G, Passacatini LC, et al. Role of the androgen receptor in melanoma aggressiveness. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07350-4.","DOI":"10.1038\/s41419-025-07350-4"},{"key":"1440_CR20","doi-asserted-by":"publisher","unstructured":"Dratwa M, Wysocza\u0144ska B, \u0141acina P, Kubik T, Bogunia-Kubik K. TERT\u2014regulation and roles in cancer formation. Front Immunol. 2020;11:589929. https:\/\/doi.org\/10.3389\/fimmu.2020.589929.","DOI":"10.3389\/fimmu.2020.589929"},{"issue":"1","key":"1440_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/oncolo\/oyad208","volume":"29","author":"ZT El","year":"2024","unstructured":"El ZT, Machaalani M, Nawfal R, Nassar AH, Xie W, Choueiri TK, et al. TERT promoter mutations frequency across race, sex, and cancer type. Oncologist. 2024;29(1):8\u201314. https:\/\/doi.org\/10.1093\/oncolo\/oyad208.","journal-title":"Oncologist"},{"key":"1440_CR22","doi-asserted-by":"publisher","unstructured":"Garrison ZR, Hall CM, Fey RM, Clister T, Khan N, Nichols R, et al. Advances in early detection of melanoma and the future of at-home testing Life. 2023;13(4). https:\/\/doi.org\/10.3390\/life13040974.","DOI":"10.3390\/life13040974"},{"key":"1440_CR23","doi-asserted-by":"publisher","unstructured":"Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3). https:\/\/doi.org\/10.1016\/j.soncn.2013.06.002.","DOI":"10.1016\/j.soncn.2013.06.002"},{"key":"1440_CR24","doi-asserted-by":"publisher","unstructured":"Guo Y, Chen Y, Zhang L, Ma L, Jiang K, Yao G, et al. TERT promoter mutations and telomerase in melanoma. J Oncol. 2022;2022:6300329. https:\/\/doi.org\/10.1016\/j.soncn.2013.06.002.","DOI":"10.1016\/j.soncn.2013.06.002"},{"key":"1440_CR26","doi-asserted-by":"publisher","unstructured":"Hafezi F, Perez Bercoff D. The solo play of TERT promoter mutations. Cells. 2020;9(3). https:\/\/doi.org\/10.3390\/cells9030749.","DOI":"10.3390\/cells9030749"},{"key":"1440_CR27","doi-asserted-by":"publisher","unstructured":"Hale CS, Qian M, Ma MW, Scanlon P, Berman RS, Shapiro RL, et al. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis. Am J Surg Pathol. 2013;37(6). https:\/\/doi.org\/10.1097\/PAS.0b013e31827e50fa.","DOI":"10.1097\/PAS.0b013e31827e50fa"},{"key":"1440_CR28","doi-asserted-by":"publisher","unstructured":"Hansen MEB, Hunt SC, Stone RC, Horvath K, Herbig U, Ranciaro A, et al. Shorter telomere length in Europeans than in Africans due to polygenetic adaptation. Hum Mol Genet. 2016;25(11). https:\/\/doi.org\/10.1093\/hmg\/ddw070.","DOI":"10.1093\/hmg\/ddw070"},{"key":"1440_CR29","doi-asserted-by":"crossref","unstructured":"Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107(1). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0092867401005049?via%3Dihub","DOI":"10.1016\/S0092-8674(01)00504-9"},{"issue":"1","key":"1440_CR30","doi-asserted-by":"publisher","first-page":"e13194","DOI":"10.1111\/pcmr.13194","volume":"38","author":"P Hersey","year":"2025","unstructured":"Hersey P, Tseng HY, Alavi S, Tiffen J. X and Y differences in melanoma survival between the\u00a0sexes. Pigment Cell Melanoma Res. 2025;38(1):e13194. https:\/\/doi.org\/10.1111\/pcmr.13194.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1440_CR31","doi-asserted-by":"publisher","unstructured":"Hiyama E, Hiyama K. Telomere and telomerase in stem cells. Br J Cancer. 2007;96(7). https:\/\/doi.org\/10.1038\/sj.bjc.6603671.","DOI":"10.1038\/sj.bjc.6603671"},{"key":"1440_CR32","doi-asserted-by":"publisher","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science (80- ). 2013;339(6122). https:\/\/doi.org\/10.1126\/science.1230062.","DOI":"10.1126\/science.1230062"},{"key":"1440_CR33","doi-asserted-by":"publisher","unstructured":"Hornsby PJ. Telomerase and the aging process. Exp Gerontol. 2007;42(7). https:\/\/doi.org\/10.1016\/j.exger.2007.03.007.","DOI":"10.1016\/j.exger.2007.03.007"},{"key":"1440_CR34","doi-asserted-by":"publisher","unstructured":"Inamdar GS, Madhunapantula SRV, Robertson GP. Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail. Biochem Pharmacol. 2010;80(5). https:\/\/doi.org\/10.1016\/j.exger.2007.03.007.","DOI":"10.1016\/j.exger.2007.03.007"},{"key":"1440_CR35","doi-asserted-by":"publisher","unstructured":"Killedar A, Stutz MD, Sobinoff AP, Tomlinson CG, Bryan TM, Beesley J, et al. A common cancer risk-associated allele in the hTERT locus encodes a dominant negative inhibitor of telomerase. PLoS Genet. 2015;11(6). https:\/\/doi.org\/10.1371\/journal.pgen.1005286.","DOI":"10.1371\/journal.pgen.1005286"},{"key":"1440_CR36","doi-asserted-by":"publisher","unstructured":"Kim SH, Richardson M, Chinnakannu K, Bai VU, Menon M, Barrack ER, et al. Androgen receptor interacts with telomeric proteins in prostate cancer cells. J Biol Chem. 2010;285(14). https:\/\/doi.org\/10.1074\/jbc.M109.098798.","DOI":"10.1074\/jbc.M109.098798"},{"key":"1440_CR37","doi-asserted-by":"publisher","unstructured":"Kim HJ, Kim YH. Molecular frontiers in melanoma: pathogenesis, diagnosis, and therapeutic advances. Intern J Mol Sci 2024;25(5). https:\/\/doi.org\/10.3390\/ijms25052984.","DOI":"10.3390\/ijms25052984"},{"key":"1440_CR38","doi-asserted-by":"publisher","unstructured":"Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurn-Little S, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet. 2013;22(12). https:\/\/doi.org\/10.1093\/hmg\/ddt086.","DOI":"10.1093\/hmg\/ddt086"},{"issue":"2","key":"1440_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/21541264.2016.1160173","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Tergaonkar V. Telomerase reactivation in cancers: mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promoters. Transcription. 2016;7(2):44\u20139. https:\/\/doi.org\/10.1080\/21541264.2016.1160173.","journal-title":"Transcription"},{"key":"1440_CR40","doi-asserted-by":"publisher","unstructured":"Ly CL, Blaha O, Wei W, Galan A, Kluger H, Ariyan S, et al. Predictive accuracy of elevated mitotic rate on lymph node positivity and recurrence in thin melanomas. Front Oncol. 2023;12:1077226. https:\/\/doi.org\/10.3389\/fonc.2022.1077226.","DOI":"10.3389\/fonc.2022.1077226"},{"key":"1440_CR41","doi-asserted-by":"publisher","unstructured":"Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012;104(11). https:\/\/doi.org\/10.1093\/jnci\/djs222.","DOI":"10.1093\/jnci\/djs222"},{"key":"1440_CR42","doi-asserted-by":"publisher","unstructured":"Morgese F, Sampaolesi C, Torniai M, Conti A, Ranallo N, Giacchetti A, et al. Gender differences and outcomes in patients with melanoma. Oncol Ther. 2020;8(1). https:\/\/doi.org\/10.1007\/s40487-020-00109-1.","DOI":"10.1007\/s40487-020-00109-1"},{"key":"1440_CR43","doi-asserted-by":"publisher","unstructured":"Murali T, Schwartz M, Reynolds AZ, Luo L, Ridgeway G, Busam KJ, et al. Sex differences in melanoma survival - A GEM study. JNCI Cancer Spectr. 2025;9(1). https:\/\/doi.org\/10.1093\/jncics\/pkaf005.","DOI":"10.1093\/jncics\/pkaf005"},{"key":"1440_CR44","doi-asserted-by":"publisher","unstructured":"Nagore E, Heidenreich B, Rachakonda S, Garcia-Casado Z, Requena C, Soriano V, et al. TERT promoter mutations in melanoma survival. Int J Cancer. 2016a;139(1). https:\/\/doi.org\/10.1002\/ijc.30042","DOI":"10.1002\/ijc.30042"},{"key":"1440_CR45","doi-asserted-by":"publisher","unstructured":"Nagore E, Heidenreich B, Requena C, Garc\u00eda-Casado Z, Martorell-Calatayud A, Pont-Sanjuan V, et al. TERT promoter mutations associate with fast-growing melanoma. Pigment Cell Melanoma Res. 2016b.29(2). https:\/\/doi.org\/10.1111\/pcmr.12441.","DOI":"10.1111\/pcmr.12441"},{"key":"1440_CR46","doi-asserted-by":"publisher","unstructured":"Parris CN, Jezzard S, Silver A, MacKie R, McGregor JM, Newbold RF. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer. 1999;79(1). https:\/\/doi.org\/10.1038\/sj.bjc.6690010.","DOI":"10.1038\/sj.bjc.6690010"},{"key":"1440_CR47","doi-asserted-by":"publisher","unstructured":"Pluta J, Pyle LC, Nead KT, Wilf R, Li M, Mitra N, et al. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat Commun. 2021;12(1). https:\/\/doi.org\/10.1038\/s41467-021-24334-y.","DOI":"10.1038\/s41467-021-24334-y"},{"key":"1440_CR48","doi-asserted-by":"publisher","unstructured":"Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, et al. Telomere length and survival in primary cutaneous melanoma patients. Sci Rep. 2018;8(1). https:\/\/doi.org\/10.1002\/ijc.30042.","DOI":"10.1002\/ijc.30042"},{"key":"1440_CR49","doi-asserted-by":"publisher","unstructured":"Ramirez RD, D\u2019Atri S, Pagani E, Faraggiana T, Lacal PM, Taylor RS, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia. 1999;1(1). https:\/\/doi.org\/10.1038\/sj.neo.7900004.","DOI":"10.1038\/sj.neo.7900004"},{"key":"1440_CR50","doi-asserted-by":"publisher","unstructured":"Ricci C, Morandi L, Ambrosi F, Righi A, Gibertoni D, Maletta F, et al. Intron 4\u20135 hTERT DNA hypermethylation in Merkel cell carcinoma: frequency, association with other clinico-pathological features and prognostic relevance. Endocr Pathol. 2021;32(3). https:\/\/doi.org\/10.1007\/s12022-021-09669-y.","DOI":"10.1007\/s12022-021-09669-y"},{"key":"1440_CR51","doi-asserted-by":"publisher","unstructured":"Rocca MS, Benna C, Mocellin S, Rossi CR, Msaki A, Di Nisio A, et al. E2F1 germline copy number variations and melanoma susceptibility. J Transl Med. 2019;17(1). https:\/\/doi.org\/10.1186\/s12967-019-1933-0.","DOI":"10.1186\/s12967-019-1933-0"},{"key":"1440_CR52","doi-asserted-by":"publisher","unstructured":"Rocca MS, Foresta C, Ferlin A. Telomere length: Lights and shadows on their role in human reproduction. Biol Reprod. 2019;100(2). https:\/\/doi.org\/10.1093\/biolre\/ioy208.","DOI":"10.1093\/biolre\/ioy208"},{"key":"1440_CR53","doi-asserted-by":"publisher","unstructured":"Rossiello F, Jurk D, Passos JF, di d\u2019Adda Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022;24(2). https:\/\/doi.org\/10.1038\/s41556-022-00842-x.","DOI":"10.1038\/s41556-022-00842-x"},{"key":"1440_CR54","doi-asserted-by":"publisher","unstructured":"Schwartz MR, Luo L, Berwick M. Sex differences in melanoma. Curr Epidemiol Rep. 2019;6(2). https:\/\/doi.org\/10.1007\/s40471-019-00192-7.","DOI":"10.1007\/s40471-019-00192-7"},{"key":"1440_CR55","doi-asserted-by":"publisher","unstructured":"Sekaran VG, Soares J, Jarstfer MB. Structures of telomerase subunits provide functional insights. Biochim Biophys Acta Proteins Proteomics. 2010;1804(5). https:\/\/doi.org\/10.1016\/j.bbapap.2009.07.019.","DOI":"10.1016\/j.bbapap.2009.07.019"},{"key":"1440_CR56","doi-asserted-by":"publisher","unstructured":"Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. Hereditary melanoma: Update on syndromes and management Genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016;74(3). https:\/\/doi.org\/10.1016\/j.jaad.2015.08.037.","DOI":"10.1016\/j.jaad.2015.08.037"},{"key":"1440_CR57","doi-asserted-by":"publisher","unstructured":"Taheri M, Ghafouri-Fard S, Najafi S, Kallenbach J, Keramatfar E, Atri Roozbahani G, et al. Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. Cancer Cell Int. 2022;22(1). https:\/\/doi.org\/10.1186\/s12935-022-02678-9.","DOI":"10.1186\/s12935-022-02678-9"},{"key":"1440_CR58","doi-asserted-by":"publisher","unstructured":"Toussi A, Mans N, Welborn J, Kiuru M. Germline mutations predisposing to melanoma. J Cutaneous Pathol 2020;47(7). https:\/\/doi.org\/10.1111\/cup.13689.","DOI":"10.1111\/cup.13689"},{"key":"1440_CR59","doi-asserted-by":"publisher","unstructured":"Tsatmali M, Ancans J, Thody AJ. Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem 2002;50(2). https:\/\/doi.org\/10.1177\/002215540205000201.","DOI":"10.1177\/002215540205000201"},{"key":"1440_CR60","doi-asserted-by":"publisher","unstructured":"Vallarelli AF, Rachakonda PS, Andr\u00e9 J, Heidenreich B, Riffaud L, Bensussan A, et al. TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation. Oncotarget. 2016;7(33). https:\/\/doi.org\/10.18632\/oncotarget.10634.","DOI":"10.18632\/oncotarget.10634"},{"key":"1440_CR61","doi-asserted-by":"publisher","unstructured":"Victorelli S, Passos JF. Telomeres and cell senescence - size matters not. EBioMedicine. 2017;21. https:\/\/doi.org\/10.1016\/j.ebiom.2017.03.027.","DOI":"10.1016\/j.ebiom.2017.03.027"},{"key":"1440_CR62","doi-asserted-by":"publisher","unstructured":"Zhou J, Richardson M, Reddy V, Menon M, Barrack ER, Prem-Veer Reddy G, et al. Structural and functional association of androgen receptor with telomeres in prostate cancer cells. Aging (Albany NY). 2013;5(1). https:\/\/doi.org\/10.18632\/aging.100524.","DOI":"10.18632\/aging.100524"},{"key":"1440_CR63","doi-asserted-by":"publisher","unstructured":"Zins K, Peka E, Miedl H, Ecker S, Abraham D, Schreiber M. Association of the telomerase reverse transcriptase rs10069690 polymorphism with the risk, age at onset and prognosis of triple negative breast cancer. Int J Mol Sci. 2023;24(3). https:\/\/doi.org\/10.3390\/ijms24031825.","DOI":"10.3390\/ijms24031825"},{"key":"1440_CR64","doi-asserted-by":"publisher","unstructured":"Zocchi L, Lontano A, Merli M, Dika E, Nagore E, Quaglino P, et al. Familial melanoma and susceptibility genes: a review of the most common clinical and dermoscopic phenotypic aspect, associated malignancies and practical tips for management. J Clin Med. 2021;10(16). https:\/\/doi.org\/10.3390\/jcm10163760.","DOI":"10.3390\/jcm10163760"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01440-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01440-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01440-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:40:54Z","timestamp":1774615254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01440-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1440"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01440-5","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethics Committee (number 2\/2020). The study was conducted according to Helsinki Declaration principles, and all patients gave their consent to have their anonymised data used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"42"}}